Clindamycin phosphate in severe infections mainly caused by Bacteroides fragilis: clinical and microbiological evaluation.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to E Yourassowsky.
Explore the source record for details and available documents.
The quantitative study (counting and size and surface evaluation of bacterial colonies) of the activity of an antimicrobial agent against a microbial population growing in solid medium can be performed by an electronic image analyzer. The Zeiss Micro-Videomat allowed the detection of even slight antimicrobial effects, which would be difficult to detect by colony counting alone and would escape the manual procedures of observation. The potential of the new method of investigation was illustrated by the examination of Staphylococcus aureus inhibition zones produced by disks of penicillin G and sulfadiazine.
When tested on Wellcotest (sensitivity test agar, Wellcome) supplemented with lysed horse blood, 59 clinical isolates of beta-haemolytic streptococci, belonging to several serological groups, are all sensitive to sulphamethoxazole, to trimethoprim, and to cotrimoxazole. The results obtained on diagnostic sensitivity test agar (Oxoid) containing lysed horse blood are comparable. When Mueller Hinton agar (Difco) is used, some of these strains are called resistant: this is especially true in the case of sulphamethoxazole.Furthermore, on Mueller Hinton agar, even supplemented with lysed blood, discrepancies between diameters of inhibition zone and MIC values exist for the three drugs tested, strains with a low MIC being considered resistant by the disc method. Such disagreements are not observed with non-streptococcal control strains.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.